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Abstract
Sphingosine-1-phosphate receptor (S1PR) activation plays a key role in vascular inflammatory response. Here, we report in vivo
validation of [11C]TZ3321, a potent S1PR1 radioligand, for imaging vascular inflammation in a rat model of carotid injury. The right
common carotid artery of male adult Sprague-Dawley rats was injured by balloon overinflation that denuded the endothelium and
distended the vessel wall. Animals received a 60-minute micro-positron emission tomography (micro PET) scan with
[11C]TZ3321 at 72 hours after injury. Ex vivo autoradiography was also conducted. The expression and cellular location of S1PR1
were examined by immunohistological analysis. Three-dimensional (3D) reconstruction of the first 100-second microPET/
computed tomography (CT) image indicated the location of bilateral common carotid arteries. [11C]TZ3321 displayed significantly higher accumulation (standardized uptake values: 0.93 + 0.07 vs 0.78 + 0.09, n ¼ 6, P ¼ .001) in the injured carotid artery
than in the contralateral side. Increased tracer uptake in the injured artery was confirmed by autoradiography (photostimulated
luminescence measures: 85.5 + 0.93 vs 71.48 + 6.22, n ¼ 2). Concordantly, high S1PR1expression was observed in infiltrated
inflammatory cells in the injured artery. Our studies demonstrate [11C]TZ3321 microPET is able to detect the acute upregulation
of S1PR1 expression in inflamed carotid artery. Therefore, [11C]TZ3321 has potential to be a PET radiotracer for detecting early
inflammatory response and monitoring therapeutic efficacy of vascular inflammation.
Keywords
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Introduction
Recent therapeutic advances have led to a decrease in cardiovascular morbidity and mortality. Despite this reduction, vascular disease remains a global health concern with associated
costs. Positron emission tomography (PET) imaging, which
can noninvasively quantify in vivo pathological processes
occurring within the arterial system, could be used for early
diagnosis and monitoring therapeutic effects. Currently, [18F]Fludeoxyglucose (FDG) is the most commonly used PET tracer
in vascular imaging. However, FDG-PET highlights all regions
of high-glucose metabolism but lacks target specificity, which
is the major shortcoming.1 To overcome this limitation, ligands
for specific targets involved in vascular pathologies have been
developed and radiolabeled for PET imaging.
Sphingosine-1-phosphate (S1P), which binds to 5 G
protein–coupled receptors (S1PR1 to S1PR5), is a bioactive
lipid with key functions in the immune, inflammatory, and

cardiovascular systems.2 In particular, S1PR1 is expressed in
endothelial cells and vascular smooth muscle cells (VSMCs),
as well as in most leucocytes.2 The activation and/or upregulation of S1PR1 are involved in various vascular pathologies,3,4
including atherosclerosis and restenosis, a major cause of
morbidity in both developed and developing countries. Thus,
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Figure 1. The representative micro-positron emission tomography (micro PET) images of balloon injured rat carotid artery using a potent
sphingosine-1-phosphate receptor 1 (S1PR1) PET radiotracer [11C]TZ3321. MicroPET image (A, two-dimensional[2D] image) and coregistered
PET/computed tomography [CT] image of the first 100-second scan (B, three-dimensional (3D) image) indicated the blood perfusion in bilateral
carotid arteries and were used to locate bilateral common carotid arteries. MicroPET image (C, 2D image) of the totally 60-minute scan showed
higher tracer uptake in the injured carotid artery area than the sham side. D, the molecular structure of [11C]TZ3321.

S1PR1 provides a potential target for both therapeutic and in
vivo imaging purposes.
Investigations of arterial response to mechanical injury
offer potential clues for human atherosclerosis etiology and
restenosis.5 The rat carotid artery balloon injury model is a
well-established animal model that utilizes mechanical damage
caused by a balloon catheter and results in mural distension and
the removal of the endothelial lining. Endothelial denudation
leads to an acute inflammatory response, the activation and
deposition of platelets with recruitment of circulating leucocytes, followed by the adaptive response, including VSMC
proliferation, migration, and the establishment of an invasive
neointima.6 In line with the acute inflammatory response, the
S1PR1 messenger RNA level of the injured artery is dramatically increased at 72 hours postinjury.3 Therefore, in vivo measurement of S1PR1, via a S1PR1-specific radiolabeled PET
tracer, could be useful for monitoring vascular inflammation.
We previously reported the synthesis and radiolabeling of a
potent S1PR1 ligand TZ3321 (3-((2-fluoro-4-(5-(20 -methyl-2(trifluoromethyl)-[1,1 0 -biphenyl]-4-yl)-1,2,4-oxadiazol3-yl)benzyl)methyl)amino)-propanoic acid, Figure 1D), which
shows high in vitro binding potency (Half maximal inhibitory
concentration IC50 ¼ 2.13 + 1.63 nM) and selectivity toward
S1PR1 (IC50 values >1000 nM for S1PR2 and S1PR3).7 The
radioligand [11C]TZ3321 has been successfully utilized to detect
in vivo inflammatory conditions by microPET scan in 2

different rodent models.7,8 The aim of the current study is
to investigate the possibility of assessing the change of
S1PR1 levels in the arterial wall during acute vascular inflammation using [11C]TZ3321 PET.

Materials and Methods
Radiosynthesis
The radioligand [ 11 C]TZ3321 was produced as reported
recently by our group.7 The radioactive product was obtained
with radiochemistry yield of 60 + 10% (n > 10, decay corrected to the end of bombardment [EOB]); specific activity of
152 - 575 GBq/mmol (n > 10, decay corrected to EOB); and
chemical purity and radiochemical purity >98% (n > 10).

Rat Carotid Artery Balloon Injury Model
All animal experiments were conducted in compliance with the
Guidelines for the Care and Use of Research Animals under
protocols approved by Washington University’s Animal
Studies Committee. Mature, male Sprague-Dawley (SD) rats
(Charles River Laboratories, Inc, Wilmington, Massachusetts)
were used for all experiments.
The rat carotid artery balloon injury procedure was carried
out according to published methods.9 Briefly, 350 to 700 g male
SD rats were anesthetized with isoflurane (1-3%). The
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trifurcation of the right common carotid artery with the external
and internal carotid branches was exposed by a ventral skin
incision and blunt dissection. Sterile sutures were placed around
the common and external carotid artery (ECA) branch in order to
isolate the ECA branch for vascular access and to control blood
flow. A deflated sterile balloon catheter (2F Fogarty, Edwards
Lifesciences, Irvine, California) was introduced through an
arteriotomy in the external branch and passed proximally down
the common carotid into the aorta. Slight inflation of the balloon
with saline and withdrawal of the catheter identified when it
began to engage the brachiocephalic artery. The balloon pressure
was then decreased just enough to allow the withdrawal of the
catheter with rotation along the full length of the common carotid artery to the area of the carotid trifurcation. The balloon was
then deflated, and this procedure was repeated 3 times. The
arteriotomy was closed proximally, and blood flow through the
common carotid artery was restored. The contralateral (left)
common carotid artery and branches were similarly exposed
without ligation or catheterization as a sham control.

MicroPET Imaging and Data Process
Small-animal microPET imaging was performed at *72 hours
following carotid injury on an Inveon PET/CT system (Siemens
Inc, Knoxville, Tennessee). Positron emission tomography scans
were conducted under light anesthesia (*2% isoflurane) delivered by a nose cone. The rats were secured using a customdesigned acrylic restraining device, with their head and neck
inside the field of the window of the Inveon PET/CT system.
Following a transmission scan and a computed tomography (CT)
for anatomical coregistration, animals received a bolus intravenous (IV) injection of [11C]TZ3321 (19-37 MBq). A list-mode
protocol was used with 60-minute dynamic data acquisition.
Image reconstructions were performed and analyzed using
microPET Manager 2.3.3.6, ASIPro 6.3.3.0 (Siemens Inc) and
Inveon Research Workstation built-in software IRW 4.2 program (Siemens Inc). The list-mode data of the emission scans
were reframed into a dynamic sequence of 1  3 s, 6  2 s, 9 
5 s, 6  10 s, 4  30 s, 2  60 s, 2  2 min, 10  5 min frames.
The data were reconstructed per time frame using an iterative
reconstruction algorithm and corrected for decay, random coincidences, scatter, and attenuation. Regions of interest (ROIs)
were drawn over the summary of the first 100-second images,
which indicated the blood perfusion in bilateral carotid arteries.
Time-activity curves (TACs) were obtained and were
expressed as dimensionless standardized uptake values
(SUVs). The parameter SUV is defined as (tissue activity
concentration [MBq/g]  body weight (g)/injected dose
[MBq]). Two-tailed paired t test was used for the comparison
of the tracer uptake in bilateral carotid arteries. A P value less
than .05 was considered statistically significant.

Ex Vivo Autoradiography
Ex vivo autoradiography was performed at *72 hours following the carotid injury. Rats were euthanized at 30 minutes
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following a bolus injection of [11C]TZ3321 (74-110 MBq).
Bilateral common carotid arteries were then dissected and cut
in half. One half of the artery was fixed in 10% formalin and
processed for histological and immunohistochemical examination. The other half was exposed immediately to a BAS storage
phosphor screen (BAS-IP-MS-2025) in an imaging cassette for
2 hours at 80 C. The distribution of radioactivity was visualized by a Fuji Bio-Imaging Analyzer FLA-7000 (Fuji Film,
Tokyo, Japan). Photostimulated luminescence was quantified
using Multi Gauge v3.0 software. Data were background corrected and expressed as photostimulated luminescence signals
per square millimeter (PSL/mm2).

Histological and Immunological Analysis
Carotid artery samples were fixed in 10% formalin, then
embedded in paraffin and cut into 5 mm sections. Hematoxylin
and eosin (H&E) staining was performed to visualize lesion
morphology of carotid arteries. For immunohistochemical analysis of S1PR1 expression, sections were deparaffinized in xylene
and rehydrated through a graded alcohol series to water. Endogenous peroxidase activity was quenched with 3% H2O2 in
methanol for 5 minutes. Slides were incubated in blocking buffer
for 30 minutes before the incubation with a 1:50 dilution of a
rabbit anti-rat S1PR1 antibody (Santa Cruz biotechnology, Santa
Cruz, California) overnight at 4 C. The primary antibody binding was detected using an anti-rabbit horseradish peroxidase3,30 -diaminobenzidine (HRP-DAB) staining kit (R&D Systems,
Minneapolis, Minnesota) according to the manufacturer’s
instructions. To further identify cell types expressing S1PR1
receptor, immunofluorescence was performed. Sections were
incubated in blocking buffer for 60 minutes following deparaffinization, rehydration, and endogenous peroxidase deactivation.
The primary antibodies were added as a mixture (rabbit anti-rat
S1PR1 [1:50] and mouse anti-rat Cluster of Differentiation 68
(CD68) [1:100, Abcam, Cambridge, Massachusetts]/CD3 [1:50,
Santa Cruz biotechnology]/HIS48 [1:50, Santa Cruz biotechnology] antibodies) and incubated with the slides at 4 C overnight.
The secondary fluorescently labeled antibodies (fluoresceinconjugated goat anti-mouse immunoglobulin G (IgG) antibody
[1:100, Jackson ImmunoResearch Lab, West Grove, Pennsylvania] and rhodamine-conjugated donkey anti-rabbit IgG antibody
[1:100, Jackson ImmunoResearch Lab]) were added and incubated in the dark for 60 minutes. A Nikon E600 (Nikon Instruments Inc., Melville, New York) microscope coupled with a
charge-coupled device camera was used to obtain all
photomicrographs.

Results
MicroPET Studies
The summary of the first 100-second microPET scan images
(Figure 1A) and 3D reconstruction of microPET/CT scans in
the same period (Figure 1B), which indicated the blood perfusion in bilateral carotid arteries, successfully located
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Figure 2. Tissue Time-activity curves (TACs) of [11C]TZ3321 uptake in balloon injured rat carotid artery. Both the representative TACs (A)
and the quantification of tracer uptake in 15 to 50-minute postinjection (B) revealed a 19.6% increase (standardized uptake values: 0.93 + 0.07
vs 0.78 + 0.09, n ¼ 6, P ¼ .001) of standardized uptake value (SUV) at 72 hours following the balloon injury.

Figure 3. Ex vivo autoradiography of [11C]TZ3321 in balloon injured rat carotid artery. Representative autoradiographic images (A) and the
quantification (B, n ¼ 2) confirmed the increased tracer uptake in the injured artery. PSL/mm2 indicates photostimulated luminescence signals
per square millimeter.

bilateral common carotid arteries. The total summary of 1hour microPET scan images (Figure 1C) indicated higher
uptake of [11C]TZ3321 in the right common carotid artery
region (the injured side) than in the contralateral artery
region (the sham side) at 72 hours postinjury. Tissue timeactivity curves of [11C]TZ3321 in bilateral carotid arteries
showed a peak at the very first several minutes, which indicated the washout of the radiotracer in the blood and further
verified the ROIs that were located in carotid arteries (Figure
2A). Quantification of SUV values revealed statistically
higher accumulation of [11C]TZ3321 in the injured carotid
artery than in the contralateral artery at 72 hours postinjury.
SUV values summed from 15 to 50 minutes of the scan were
0.93 + 0.07 and 0.78 + 0.09 for the injured and contralateral sides, respectively. The increase percentage was 19.6%
(n ¼ 6, P ¼ .001; Figure 2B).

Autoradiographic Studies
Ex vivo autoradiographic data showed modest uptake of
[11C]TZ3321 in the sham artery and higher tracer uptake in the
injured artery compared to the sham side (Figure 3A). The
quantification of the autoradiographic signal of [11C]TZ3321
uptake in the injured artery was 85.5 + 0.93 PSL/mm2, while
the value for the contralateral side was 71.48 + 6.22 PSL/mm2
(n ¼ 2, Figure 3B). The increase of the tracer uptake in the
injured artery (*20%) was similar to that measured by SUV
values from microPET studies, which further support the
quantification method of microPET images.

Histological and Immunological Analysis
The H&E staining showed inflammatory cell infiltration in
both intima and adventitia of the injured carotid artery but not
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Figure 4. The expression of sphingosine-1-phosphate receptor 1
(S1PR1) in balloon-injured rat carotid artery. A and B, Hematoxylin
and eosin (H&E) staining of rat carotid artery (balloon-injured and
sham). D and F showed S1PR1 is highly expressed in both intima and
adventitia of injured carotid artery. C and E revealed a low level of
S1PR1 expression in normal carotid artery. Red/white arrows indicated infiltrated cells (B) or S1PR1-positive cells (D and F). Blue and
green dash lines indicated the boundary of intima, media, and
adventitia.

in the sham artery (Figure 4). Immunohistochemical staining
and immunofluorescence revealed high expression of S1PR1 in
these infiltrated cells (Figure 4), which is in agreement with the
increased tracer uptake of [11C]TZ3321 in the injured artery.
To further explore the cellular colocation of highly expressed
S1PR1, antibodies of specific biomarkers of macrophages
(CD68), T lymphocytes (CD3), and granulocytes (HIS48) were
used for the double immunofluorescence labeling along with
S1PR1 antibody. The results showed S1PR1 was expressed on
all 3 inflammatory cell types (Figure 5).

Discussion
Inflammation plays an important role in the pathogenesis of
many forms of vascular disease, including the response to acute
vascular injury.10 Balloon injury of arteries has been shown to
elicit accumulation of leukocytes surrounding the injury site
within hours after the insult.11 The appearance of inflammatory
cells is associated with expression of adhesion molecules and
leukocyte-specific cytokines, as well as increased S1PR1 level
on the injured arteries.3 Daily intraperitoneal injection of the
S1PR1/S1PR3 antagonist VPC44116 (Ki ¼ 30 and 300 nM for
S1PR1 and S1PR3, respectively12) decreased neointimal hyperplasia by approximately 50%.3 These data suggest that S1PR1
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plays a key role in the pathological changes in response to vascular injury, and it could be a potential target for in vivo monitoring of vascular inflammation by assessing the change of S1P1
expression using PET with a suitable S1P1 radiotracer. In this
study, we demonstrated that microPET imaging with a potent
S1PR1 radioligand [11C]TZ3321 was able to detect increased
S1PR1 expression on the injured carotid artery. In addition, we
identified the major contribution of S1PR1 in infiltrated inflammatory cells 72 hours after carotid artery balloon injury.
According to the traditionally considered “inside-out”
response, the initial consequences after balloon injury are
endothelial denudation and platelet deposition. Circulating leukocytes then bind to the injured surface and migrate across the
platelet-fibrin layer and diapedesis into the tissue.10 There is
also an outside-in hypothesis, in which the inflammatory
response is orchestrated from the adventitial side of the vessel.
Clusters of resident lymphocytes generate local humoral
immune responses to produce antibodies against local antigen
presentation by foam cells and antigen-presenting cells. The
cell populations work in concert to evoke an inflammatory
response that propagates inward toward the intima.13 The histological images from our study detected rapid and obvious
infiltration of inflammatory cells in response to balloon injury
in both intima and adventitia of the carotid artery, which suggest the “inside-out” and “outside-in” progression may coexist
during the early stage of vascular inflammation. More importantly, high S1PR1 expression was observed in these infiltrated
cells, which provides a basis for in vivo detection of acute
vascular inflammation by PET imaging with a S1PR1specific radioligand. Concordantly, microPET with the potent
and specific S1PR1 radioligand [11C]TZ3321 was utilized in a
rat model of carotid artery balloon injury. The tracer uptake in
the injured carotid artery was about 19% higher than that in the
contralateral intact artery at 72 hours postinjury, which was
confirmed by ex vivo autoradiographic study.
We further investigated the cellular location of S1PR1 in the
infiltrated cells, including T lymphocytes, macrophages, and
granulocytes. S1PR1 is well known for the regulation of lymphocyte migration out of the secondary lymphoid organs into
the blood and lymph.14 FTY-720, a S1PR modulator, was the
first Food and Drug Administration–approved oral therapy for
multiple sclerosis (MS). The presumed mechanism of action
for FTY-720 has been the trapping of autoreactive lymphocytes in the lymphoid organs, away from the central nervous
system. 15 Macrophages are important sentinel cells that
develop from monocytes to fight infection and repair damaged
tissue.16 The S1PR1 expressed by monocytes and macrophages
regulates their migration and recruitment toward S1P.17 In
agreement with that, KRP-203, an S1PR1-specific agonist,
blocks S1P signaling through S1P receptor internalization and
degradation and downregulates biomarkers for macrophage
activation.18 The S1PR1 was also necessary for the recruitment
of neutrophils, which are the first immune cell line of defense
and can shape the immune response.19,20 Specific S1PR1
antagonism blocked neutrophil infiltration, whereas S1PR1
agonism increased sensitivity.21 The immunofluorescence
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Figure 5. Coregistration of S1PR1 with biomarkers of inflammatory cells in balloon-injured rat carotid artery. A, D, and G, S1PR1 immunofluorescence (red) showed high S1PR1 expression in the injured artery. B, E, and H, CD68/CD3/HIS48 immunofluorescence (green) showed the
localization of macrophages, T lymphocytes, and granulocytes in the injured artery, respectively. C, F, and I, coregistration of S1PR1 and CD68/
CD3/HIS48 immunofluorescence. White arrows indicated the colocation of S1PR1 in macrophages, T lymphocytes, and granulocytes (yellow).

imaging confirmed S1PR1 expression in these 3 inflammatory
cells in the injured site of carotid artery. Therefore, upregulated
S1PR1 level in the injured carotid artery is mainly attributed to
the infiltration of inflammatory cells that express S1PR1.
Accordingly, increased uptake of the S1PR1-specific radioligand [11C]TZ3321 in the injured artery, determined by microPET imaging and ex vivo autoradiography, is correlated with
acute inflammatory response following balloon injury. The
finding also agrees with our previous report that microPET
with [11C]TZ3321 revealed upregulated S1PR1 expression was
associated with glial cell activation and immune cell infiltration in lumbar spinal cord in a rat model of MS.8
The S1PR1-specific radioligand [11C]TZ3321 has been previously evaluated in a mouse model of vascular injury at relatively late time points (1-4 weeks postinjury). The microPET
imaging showed that [11C]TZ3321 was highly accumulated at
the injury site, where enhanced S1PR1 level resulted from
migrated VSMCs in the neointima.7 In fact, in the carotid artery
balloon injury rats, VSMC migration and proliferation are
observed 2 weeks postinjury6 and contribute to the progression
of neointima. Therefore, [11C]TZ3321 has the potential for in
vivo imaging of vascular remodeling in a early stage of carotid
injury in rats.

Vascular imaging by PET still remains a challenge, especially for preclinical studies in rodents. First, the diameter of rat
common carotid artery is close to the spatial resolution of the
Inveon microPET scanner (*1.5 mm full width at half maximum at center of field of view). Second, high tracer uptake in
surrounding organs may impact the accuracy of measuring
radioactivity in the target vessel. Nevertheless, rat carotid
artery injury and mouse femoral artery injury models provide
excellent platforms for in vivo tracer validation of
[11C]TZ3321, because both vascular injury models not only
induce significant increase of S1PR1 expression in the injury
site that is detectable by microPET but also avoid the shading
of high tracer uptake from major organs. Further investigation
on large animals and particularly on humans will facilitate the
implementation of [11C]TZ3321 in imaging vascular inflammation by quantitative PET measures of S1PR1 expression.

Conclusion
Increased expression of S1PR1 in infiltrated inflammatory cells
in carotid artery 72 hours following balloon injury in rats was
detected by microPET imaging using [11C]TZ3321 and confirmed by ex vivo autoradiography and immunohistological
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analysis. The data suggest the potential of [11C]TZ3321 as a PET
radiotracer for monitoring early inflammatory response and therapeutic efficacy aimed at reducing vascular inflammation.
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